The Editor’s Roundtable: Psoriasis, Inflammation, and Coronary Artery Disease

  • Vincent E. Friedewald Jr.
    Corresponding author: Tel: 512-264-1611; fax: 512-264-7034.
    Assistant Editor, American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Adjunct Research Professor, College of Science, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • Jennifer C. Cather
    Co-Director, Graft vs. Host Clinic, and Co-Director, Cutaneous Lymphoma Clinic, Baylor University Medical Center, Dallas, Texas
    Search for articles by this author
  • Kenneth B. Gordon
    Associate Professor of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    Search for articles by this author
  • Arthur Kavanaugh
    Professor of Medicine, University of California, San Diego, School of Medicine, and Director, Center for Innovative Therapy, University of California, San Diego, Division of Rheumatology, Allergy, and Immunology, San Diego, California
    Search for articles by this author
  • Paul M. Ridker
    Eugene Braunwald Professor of Medicine, Harvard Medical School, and Director, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Boston, Massachusetts
    Search for articles by this author
  • William C. Roberts
    Editor-in-Chief, American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas.
    Search for articles by this author
      This CME activity is supported by an educational grant from Abbott Laboratories, Abbott Park, Illinois.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gelfand J.M.
        • Neimann A.L.
        • Shin D.B.
        • Wang X.
        • Margolis D.J.
        • Troxel A.B.
        Risk of myocardial infarction in patients with psoriasis.
        JAMA. 2006; 296: 1735-1741
        • Gelfand J.M.
        • Gladman D.D.
        • Mease P.J.
        • Smith N.
        • Margolis D.J.
        • Nijsten T.
        • Stern R.S.
        Epidemiology of psoriatic arthritis in the population of the United States.
        J Am Acad Dermatol. 2005; 53: 573-577
        • Bhalerao J.
        • Bowcock A.M.
        The genetics of psoriasis: a complex disorder of the skin and immune system.
        Hum Mol Genet. 1998; 7: 1537-1545
        • Gelfand J.M.
        • Berlin J.
        • Voorhees A.V.
        • Margolis D.J.
        Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom.
        Arch Dermatol. 2003; 139: 1425-1429
        • Krueger G.
        • Koo J.
        • Lebwohl M.
        • Menter A.
        • Stern R.S.
        • Rolstad T.
        The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
        Arch Dermatol. 2001; 137: 280-284
        • Shapiron J.
        • Cohen A.D.
        • David M.
        • Hodak E.
        • Chodik G.
        • Viner A.
        • Kremet E.
        • Heymann A.
        The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
        J Am Acad Dermatol. 2007; 56: 629-634
        • McDonald C.J.
        • Calabresi P.
        Thromboembolic disorders associated with psoriasis.
        Arch Dermatol. 1973; 107: 918
        • Kremers H.M.
        • McEvoy M.T.
        • Dann F.J.
        • Gabriel S.E.
        Heart disease in psoriasis.
        J Am Acad Dermatol. 2007; 57: 347-354
        • Mallbris L.
        • Granath F.
        • Hamsten A.
        • Stahle M.
        Psoriasis is associated with lipid abnormalities at the onset of skin disease.
        J Am Acad Dermatol. 2006; 54: 614-621
        • Herron M.D.
        • Hinckley M.
        • Hoffman S.
        • Papenfuss J.
        • Hansen C.B.
        • Callis K.P.
        • Krueger G.G.
        Impact of obesity and smoking on psoriasis presentation and management.
        Arch Dermatol. 2005; 141: 1527-1534
        • Fortes C.
        • Mastroeni S.
        • Leffondre K.
        • Sampogna F.
        • Melchi F.
        • Mazzotti E.
        • Pasquini P.
        • Abeni D.
        • IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Study Group
        Relationship between smoking and the clinical severity of psoriasis.
        Arch Dermatol. 2005; 141: 1580-1584
        • Neimann A.L.
        • Shin D.B.
        • Wang X.
        • Margolis D.J.
        • Troxel A.B.
        • Gelfand J.M.
        Prevalence of cardiovascular risk factors in patients with psoriasis.
        J Am Acad Dermatol. 2006; 55: 829-835
        • Wakkee M.
        • Thio H.B.
        • Prens E.P.
        • Sijbrands E.J.G.
        • Neumann H.A.M.
        Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
        Atherosclerosis. 2007; 190: 1-9
        • Ross R.
        Atherosclerosis—an inflammatory disease.
        N Engl J Med. 1999; 340: 115-126
        • Libby P.
        What have we learned about the biology of atherosclerosis?.
        Am J Cardiol. 2001; 88: 3J-6J
        • Ridker P.M.
        C-reactive protein and the prediction of cardiovascular events among those at intermediate risk.
        J Am Coll Cardiol. 2007; 49: 2129-2138
        • Feldman S.R.
        • Krueger G.G.
        Psoriasis assessment tools in clinical trials.
        Ann Rheum Dis. 2005; 64: ii65-ii68
        • Malbris L.
        • Akre O.
        • Granath F.
        • Yin L.
        • Lindelof B.
        • Ekbom A.
        • Stahle-Backdahl M.
        Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients.
        Eur Epidemiol. 2004; 19: 225-230
        • Christensen T.E.
        • Callis K.P.
        • Papenfuss J.
        • Hoffman M.S.
        • Hansen C.B.
        • Wong B.
        • Panko J.M.
        • Krueger G.G.
        Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes.
        J Invest Dermatol. 2006; 126: 2397-2403
        • McCarey D.W.
        • McInnes I.B.
        • Madhok R.
        • Hampson R.
        • Scherbakova O.
        • Ford I.
        • Capell H.A.
        • Hattar N.
        Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
        Lancet. 2004; 363: 2015-2021
        • Friedewald V.E.
        • McPherson R.
        • Roberts R.
        • Roberts W.C.
        • Waters D.D.
        The Editor’s Roundtable: statin therapy in acute coronary syndrome.
        Am J Cardiol. 2007; 99: 213-221
        • Cannon C.P.
        • Braunwald E.
        • McCabe
        • Rader D.J.
        • Rouleau J.L.
        • Belder R.
        • Joyal S.V.
        • Hill K.A.
        • Pfeffer M.A.
        • Skene A.M.
        • Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Investigators
        Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
        N Engl J Med. 2004; 350: 1495-1504
        • Blazing M.A.
        • De Lemos J.A.
        • Dyke C.K.
        • Califf R.M.
        • Bilheimer D.
        • Braunwald E.
        The A-to-Z trial: methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy.
        Am Heart J. 2001; 142: 211-217
        • Ridker P.M.
        • Fonseca F.A.H.
        • Genest J.
        • Gotto A.M.
        • Kastelein J.J.P.
        • Khurmi N.S.
        • Koenig W.
        • Libby P.
        • Lorenzatti A.J.
        • Nordestgaard B.G.
        • et al.
        • JUPITER Trial Study Group
        Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.
        Am J Cardiol. 2007; 100: 1659-1664
      1. Third report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III final report).
        (Accessed November 4, 2007)